STAGE IIIA PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIA PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for high-risk prostate cancer: targeted drug after radiation
Disease control Recruiting nowThis study is for men with high-risk prostate cancer that hasn't spread far. It tests whether adding the drug niraparib to standard hormone therapy after radiation can keep the cancer from coming back longer. About 200 participants will receive either hormone therapy alone or hor…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Proton beam therapy aims to cut side effects in prostate cancer
Disease control Recruiting nowThis study tests a precise type of radiation called proton therapy for men with high-risk prostate cancer that has spread to lymph nodes. The goal is to see if targeting the tumor and nearby lymph nodes causes fewer bowel and bladder side effects than standard radiation. About 30…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 12, 2026 13:42 UTC